USC sold the operations of the Kenneth Norris Jr Cancer Hospital to Tenet Healthcare
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
Amgen relocated its cancer research division to Seattle
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
Stanford reserchers found that Wnt genes, first discovered as critical genes in cancer, are also critical regulators of stem cell development
On Apr. 27, 2003, Stanford researchers found that Wnt genes, first discovered as critical genes in cancer, are…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
The Institute for Collaborative Biotechnologies was founded
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
Biotechnology | Disease | FDA
Genentech drug Pegasys (peginterferon alfa-2a) approved
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
Medicine | NIH | U.S. Congress
Richard H. Carmona was sworn in as U.S. Surgeon General
On Aug. 5, 2002, President George W. Bush appointed Richard H. Carmona as U.S. Surgeon General, one of…
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Amgen’s aranesp for anemia associated with chemotherapy
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
Immunex Corp. was acquired by Amgen
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
Biotechnology | FDA | Medicine | Therapeutics
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
Biotechnology | FDA | HIV | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
Stanford researchers discovered hereditary arthritis gene
On Jul. 11, 2000, Stanford researchers announced they had identified a substance commonly added to toothpaste to prevent…
Genentech drug TNKase (tenecteplase) was approved
On June 2, 2000, the U.S. Food and Drug Administration announced it had approved Genentech’s drug TNKaseﾮ (tenecteplase)….
Stanford researchers solved the structure of the RNA polymerase protein
On Apr. 24, 2000, Stanford researchers announced they have solved the structure of the RNA polymerase protein, one…
The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower
On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….
The Stanford Hospital Center for Clinical Sciences Research building opened
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…
QB 3 was founded as the University of California’s hub for innovation and entrepreneurship in life science
In 2000, QB3 founded as the University of California’s hub for innovation and entrepreneurship in life science, with…
Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
The University of California, Riverside Center for Nanoscale Science and Engineering was established
In 2000, the University of California, Riverside Center for Nanoscale Science and Engineering was established to capitalize on…
The Buck Institute for Research on Aging opened its doors
On Sept. 30, 1999, the Buck Institute for Research on Aging, named for Marin County philanthropists Leonard and…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…